Dual mTORC1/2 inhibition in a preclinical xenograft tumor model of endometrial cancer.

Korets SB, Musa F, Curtin J, Blank SV, Schneider RJ. Dual mTORC1/2 inhibition in a preclinical xenograft tumor model of endometrial cancer. Gynecol Oncol. 2014 Feb; 132(2):468-73.

View in: PubMed

subject areas

Animals
Antineoplastic Combined Chemotherapy Protocols
Carboplatin
Carcinoma, Endometrioid
Cell Growth Processes
Cell Line, Tumor
Endometrial Neoplasms
Everolimus
Female
Indoles
Mechanistic Target of Rapamycin Complex 1
Mechanistic Target of Rapamycin Complex 2
Mice
Mice, Inbred BALB C
Mice, Nude
Multiprotein Complexes
Protein Kinase Inhibitors
Proto-Oncogene Proteins c-akt
Purines
Random Allocation
Signal Transduction
Sirolimus
TOR Serine-Threonine Kinases
Xenograft Model Antitumor Assays

authors with profiles

Sharmilee Bansal Korets MD